Laureate Pharma announces collaboration with Boehringer Ingelheim
Laureate Pharma, Inc. announced a preferred partnership agreement with Boehringer Ingelheim. With this collaboration, Laureate's clients will gain access to Boehringer Ingelheim's comprehensive manufacturing technology platform for biopharmaceutical products produced by mammalian cell culture.
Through this collaboration, Laureate will now offer its clients bioprocessing services that include: creation and development of production cell lines using Boehringer Ingelheim's highly efficient BI HEX expression system; full-service process development and manufacture of early stage clinical supplies at Laureate's cGMP manufacturing facility in Princeton, NJ; and access to large-scale commercial production by Boehringer Ingelheim at its facility in Biberach, Germany. Laureate and Boehringer Ingelheim will harmonize bioprocessing methods to ensure seamless transfer of manufacturing activities from Laureate to Boehringer Ingelheim.
Other news from the department business & finance
